Statins and Liver Cancer Prevention: A New Hope for Hepatitis C Patients?
Executive Summary: Major observational studies, including a landmark 2013 study of over 260,000 patients in Taiwan, suggest that the use of statins (common cholesterol-lowering drugs) is associated with a significantly reduced risk of developing liver cancer (HCC) in individuals with chronic hepatitis C. This protective effect appears to be dose-dependent, with higher cumulative doses linked …